Ignite Creation Date:
2025-12-24 @ 12:22 PM
Ignite Modification Date:
2025-12-27 @ 9:39 PM
Study NCT ID:
NCT06878261
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2025-03-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2029-03-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-05
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-03
First Submit QC Date:
None
Study First Post Date:
2025-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED